Basilea licenses late-stage oncology drug candidate derazantinib from ArQule
Apr 17, 2018 05:16 am UTC| Business
Basel, Switzerland, April 17, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that it has entered into a license agreement with ArQule, Inc. (NASDAQ: ARQL) for its oncology drug candidate ARQ 087...
Apr 17, 2018 05:01 am UTC| Business
REGULATED INFORMATION GHENT, Belgium, 17 April 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major...
INNATE PHARMA : AACR 2018, New preclinical data further support ongoing programs
Apr 17, 2018 05:01 am UTC| Business
new preclinical data further support ongoing programs and highlight next generation of immunotherapies Next generation of immunotherapies presented by Chief Scientific Officer Eric Vivier in a meet-the-expert...
Apr 17, 2018 05:01 am UTC| Business
WISeKey International Holding Ltd Announces Date of the 2018 Annual General Meeting and Key Agenda Items Zug, Switzerland, April 17, 2018 - WISeKey International Holding Ltd ("WISeKey" or the "Company") (SIX: WIHN), a...
Apr 17, 2018 05:00 am UTC| Business
LRRACH, Germany and SAINT LOUIS, France, April 17, 2018 -- Allecra Therapeutics (Private), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening...
Apr 17, 2018 04:01 am UTC| Business
WASHINGTON, April 17, 2018 -- The Ilan Ramon Scholarship Project is proud to release this short film, Shimon Peres, “Poet to the Stars,” on the 70th anniversary of the founding of the state of Israel. The film contains...
Apr 17, 2018 04:00 am UTC| Business
SOUTH BURLINGTON, Vt., April 17, 2018 -- Dynapower, a global leader in energy storage, is pleased to announce it has reached a master supplier agreement with Viridity Energy Solutions, Inc. to supply inverters and...